Hong Kong Stocks Movement | CRO Concept Stocks Plunge Collectively: GENSCRIPT BIO (01548) Drops Over 6%, PHARMARON (03759) Falls Over 4%

IPO Preview: "Stockpiling Monkeys" Drags Down Profits, Can Dingtai Pharma's "Water Seller" Story Hold Up?

Norges Bank Increases Stake in Pharmaron with Purchase of 700,200 Shares at HK$23.81 Each

Norges Bank Increases Stake in PHARMARON (03759) by 700,200 Shares at HK$23.81 Per Share

Norges Bank Increases Stake in PHARMARON (03759) by 518,200 Shares at HK$25.76 per Share

PHARMARON (03759) Shareholder Lou Xiaoqiang Pledges 2.154 Million Company Shares

Goldman Sachs Raises PHARMARON (03759) Target Price to HK$30, Q3 Revenue Slightly Beats Expectations

CLSA Raises Pharmaron (03759) Target Price to HK$28.8, Maintains "Outperform" Rating

UBS: Pharmaron (03759) Sees Accelerated New Order Growth in First Three Quarters, Raises Target Price to HK$32.9, Maintains "Buy" Rating

Pharmaron Acquires Majority Stake in Biortus Biosciences

Pharmaron Acquires Biortus in China

PHARMARON (03759) Nominates Professor Zeng Jinfeng as Candidate for Independent Non-Executive Director

PHARMARON (03759) Reports Q1-Q3 Results: Net Profit Attributable to Shareholders Drops 19.76% YoY to RMB1.141 Billion

Hong Kong Stocks in Focus | PHARMARON (03759) Surges Over 5% After Signing Cooperation Framework Agreement with CityU

PHARMARON (03759) Actual Controller Lou Xiaoqiang Pledges 3.45 Million Shares and Releases Pledge on 4.37 Million Shares

Pharmaron's Shaoxing Unit Passes US FDA On-Site Inspection

Pharmaron Beijing Co.,Ltd. (300759.SZ) Subsidiary Pharmaron Shaoxing Passes US FDA On-Site Inspection

Hong Kong Stock Movement | CRO Concept Stocks Rise in Morning Trading, PHARMARON (03759) Gains Over 8% as Innovative Drug Clinical Trial Review and Approval Process Accelerates Again

PHARMARON (03759): Xinzhong Kangcheng's Share Reduction Plan Completed with Total Disposal of 26.67 Million Shares

PHARMARON (03759) Reports Interim Results with Shareholders' Profit of RMB 701 Million, Down 37% Year-on-Year